Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

Giacomo Coltro; Terra L. Lasho; Christy M. Finke; Naseema Gangat; Animesh Pardanani; Ayalew Tefferi; Dragan Jevremovic; Jessica K. Altman; Mrinal M. Patnaik

doi:10.1002/ajh.25552

Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

Giacomo Coltro, Terra L. Lasho, Christy M. Finke, Naseema Gangat, Animesh Pardanani, Ayalew Tefferi, Dragan Jevremovic, Jessica K. Altman, Mrinal M. Patnaik^*

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	E231-E234
Journal	American Journal of Hematology
Volume	94
Issue number	9
DOIs	https://doi.org/10.1002/ajh.25552
State	Published - Sep 2019

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.25552

Cite this

Coltro, Giacomo ; Lasho, Terra L. ; Finke, Christy M. ; Gangat, Naseema ; Pardanani, Animesh ; Tefferi, Ayalew ; Jevremovic, Dragan ; Altman, Jessica K. ; Patnaik, Mrinal M. / Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis. In: American Journal of Hematology. 2019 ; Vol. 94, No. 9. pp. E231-E234.

@article{2d480a21b3db46d8bebe695a084efec9,

title = "Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis",

author = "Giacomo Coltro and Lasho, {Terra L.} and Finke, {Christy M.} and Naseema Gangat and Animesh Pardanani and Ayalew Tefferi and Dragan Jevremovic and Altman, {Jessica K.} and Patnaik, {Mrinal M.}",

note = "Funding Information: Informed consent from the patient was obtained to share relevant data as outlined in the manuscript, including genetic information. Current publication is supported in part by grants from the ?The Henry J. Predolin Foundation for Research in Leukemia, Mayo Clinic, Rochester, MN, USA.? This publication was supported by CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Funding Information: Informed consent from the patient was obtained to share relevant data as outlined in the manuscript, including genetic information. Current publication is supported in part by grants from the “The Henry J. Predolin Foundation for Research in Leukemia, Mayo Clinic, Rochester, MN, USA.” This publication was supported by CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.",

year = "2019",

month = sep,

doi = "10.1002/ajh.25552",

language = "English (US)",

volume = "94",

pages = "E231--E234",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "9",

}

Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis. / Coltro, Giacomo; Lasho, Terra L.; Finke, Christy M.; Gangat, Naseema; Pardanani, Animesh; Tefferi, Ayalew; Jevremovic, Dragan; Altman, Jessica K.; Patnaik, Mrinal M.

In: American Journal of Hematology, Vol. 94, No. 9, 09.2019, p. E231-E234.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

AU - Coltro, Giacomo

AU - Lasho, Terra L.

AU - Finke, Christy M.

AU - Gangat, Naseema

AU - Pardanani, Animesh

AU - Tefferi, Ayalew

AU - Jevremovic, Dragan

AU - Altman, Jessica K.

AU - Patnaik, Mrinal M.

N1 - Funding Information: Informed consent from the patient was obtained to share relevant data as outlined in the manuscript, including genetic information. Current publication is supported in part by grants from the ?The Henry J. Predolin Foundation for Research in Leukemia, Mayo Clinic, Rochester, MN, USA.? This publication was supported by CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Funding Information: Informed consent from the patient was obtained to share relevant data as outlined in the manuscript, including genetic information. Current publication is supported in part by grants from the “The Henry J. Predolin Foundation for Research in Leukemia, Mayo Clinic, Rochester, MN, USA.” This publication was supported by CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.

PY - 2019/9

Y1 - 2019/9

UR - http://www.scopus.com/inward/record.url?scp=85067345748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067345748&partnerID=8YFLogxK

U2 - 10.1002/ajh.25552

DO - 10.1002/ajh.25552

M3 - Comment/debate

C2 - 31173385

AN - SCOPUS:85067345748

VL - 94

SP - E231-E234

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 9

ER -